Home › Funds › SOFTBANK GROUP CORP. › ABCL
SOFTBANK GROUP CORP. position in ABCL
ABCELLERA BIOLOGICS INC · Health Care
SOFTBANK GROUP CORP. reported holding 345,161 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q2 2026 13F filing — a position valued at US$2.7M, representing 0.01% of its reported portfolio and ranking #26 among its reported holdings. SOFTBANK GROUP CORP. has disclosed ABCL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SOFTBANK GROUP CORP.'s ABCL position evolved
SOFTBANK GROUP CORP. first disclosed a stake in ABCL in Q4 2025 at 345,161 shares (US$1.2M). The position peaked in Q2 2026 at 345,161 shares, worth US$2.7M. Across 3 filings, SOFTBANK GROUP CORP. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 345,161 shares valued at US$2.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 345.16K | $1.18M | New |
| Q1 2026 | 345.16K | $1.20M | Hold |
| Q2 2026 | 345.16K | $2.71M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABCL and 13F data
ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 37 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$259.1M), ArrowMark Colorado Holdings LLC (US$32.2M), Guardian Partners Inc. (US$8.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABCL
- BAKER BROS. ADVISORS LP 33.01M sh · $259.15M · Q2 2026
- ArrowMark Colorado Holdings LLC 4.11M sh · $32.22M · Q2 2026
- Guardian Partners Inc. 596.00K sh · $8.70M · Q3 2026
- Intellectus Partners, LLC 551.58K sh · $4.33M · Q2 2026
More on SOFTBANK GROUP CORP.
FAQ
How long has SOFTBANK GROUP CORP. held ABCL?
SOFTBANK GROUP CORP. has disclosed ABCL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is SOFTBANK GROUP CORP.'s current position in ABCL?
As of Q2 2026, SOFTBANK GROUP CORP. holds 345.16K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $2.71M, representing 0.01% of its reported portfolio and ranking #26.
Has SOFTBANK GROUP CORP. been buying or selling ABCL?
In the latest 13F filing (Q2 2026), SOFTBANK GROUP CORP. held unchanged its position in ABCL. The position peaked in Q2 2026 at 345.16K shares.
Which other funds hold ABCL?
Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, Guardian Partners Inc., among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.